Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.0K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K
Seizures: Classification01:13

Seizures: Classification

1.2K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

621
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
621
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

1.5K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.5K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.1K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

796
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
796

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetes, impaired fasting glucose, and cognitive trajectories: a multi-cohort study.

medRxiv : the preprint server for health sciences·2026
Same author

Performance of six screening scores for obstructive sleep apnoea in an African population: findings from the BeSAS cross-sectional study.

Sleep medicine: X·2026
Same author

Development, psychometric validation, and correlates of the 15-item quality of life in epilepsy scale (QOLIE-15).

Scientific reports·2026
Same author

Obituary: Michel Dumas (1934-2025) - A Founding Figure of Tropical Neuroepidemiology.

Neuroepidemiology·2026
Same author

Effects of an Educational Comic Book on Knowledge, Attitudes, and Practices Regarding Epilepsy among Adolescents in Quito, Ecuador.

Neuroepidemiology·2026
Same author

Evaluation of use and efficacy of African traditional medicine for metabolic syndrome: a systematic review.

Journal of epidemiology and population health·2026

Related Experiment Videos

[Epilepsy in tropical areas].

Michel Dumas1, Pierre-Marie Preux

  • 1Institut de neurologie tropicale, Faculté de Médecine, 2, rue du Docteur Marcland, 87025 Limoges cedex. ient@unilim.fr

Bulletin De L'Academie Nationale De Medecine
|February 26, 2009
PubMed
Summary

Epilepsy is a severe public health issue in tropical and developing regions, with higher prevalence and mortality rates. Addressing neglect, stigma, and treatment access is crucial for improving patient outcomes.

Area of Science:

  • Neurology
  • Public Health
  • Tropical Medicine

Context:

  • Epilepsy presents unique challenges in tropical and developing countries, including higher prevalence (2-10x) and incidence (2x) compared to Western nations.
  • Significant neglect by authorities and the World Health Organization (WHO) hinders efforts to address epilepsy as a major public health problem.
  • High mortality rates and limited access to appropriate treatment exacerbate the burden of epilepsy in these regions.

Purpose:

  • To highlight the specific characteristics and public health implications of epilepsy in tropical and developing countries.
  • To underscore the need for increased awareness, improved healthcare access, and culturally sensitive communication strategies.
  • To advocate for the utilization of existing guidelines and the development of targeted training programs for healthcare personnel.

Related Experiment Videos

Summary:

  • Epilepsy in tropical areas is characterized by higher prevalence, incidence, and mortality, often linked to specific etiologies like perinatal disorders and parasitic infections.
  • Despite established guidelines and awareness campaigns, epilepsy remains neglected, stigmatized, and inadequately treated in many developing countries.
  • Effective management requires addressing cultural perceptions, improving healthcare worker training, ensuring access to quality medication, and combating counterfeit drugs.

Impact:

  • Increased understanding of the disproportionate burden of epilepsy in tropical and developing regions.
  • Provides a framework for targeted interventions to reduce mortality, improve treatment access, and combat stigma associated with epilepsy.
  • Emphasizes the critical need for global health initiatives and local healthcare system strengthening to manage epilepsy effectively.